NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » Companies » Medicom
Medicom

Medicom

About Medicom

Medicom, a Phillips-Medisize company, discusses the rise of smart device solutions and connected health services with World Pharmaceutical Frontiers, and focuses on how these tools enable direct interaction with end users by using real-life data. This interaction, combined with data and learning loops from these services, can differentiate drugs to meet demand in specific micro-segments.


Products & Services
NO DATA FOUND
Press releases
NO DATA FOUND
Contact Medicom

ABOUT Medicom


SECTOR: Pharmaceuticals

SUB SECTOR: Drug Delivery Systems     

SPECIALITY: Drug Delivery Systems

Medicom, a Phillips-Medisize company, discusses the rise of smart device solutions and connected health services with World Pharmaceutical Frontiers, and focuses on how these tools enable direct interaction with end users by using real-life data. This interaction, combined with data and learning loops from these services, can differentiate drugs to meet demand in specific micro-segments.

The market model for traditional pharmaceuticals, which is based on formulary positioning and prescriptions given by doctors, has been under pressure, giving rise to an end-user and consumer-driven approach. In addition to this, changes in payment models have been linked to positive patient outcomes, otherwise known as ‘payment by results’.

For pharmaceuticals, the concept of patient centricity is a major trend, where industry trends – including more defined clinical/regulatory approaches, an increased number of biologic drugs, higher-drug specificity and treatments linked to diagnostic data – are combining with a subsegmentation approach that concerns patients and where drugs can be most effective. While efficacy and safety are still fundamental for gaining drug approval, it is also important to note that exploring and understanding the care journey provides valuable insight into the needs of stakeholders, as well as the basis for defining services that are essential for stakeholders and patients in subsegments. A service model that is dedicated to the drug will be able to meet individual and segment needs, including secondary disease measures, monitoring, and adherence and compliance services.

Smooth interaction with stakeholders is important for deriving value from this drug/service differentiation. This change in the stakeholder/patient engagement equation evidences that bespoke connected health services are proving to be vital tools.

A fast-moving-consumer-goods approach

Connected health services could make significant changes to the market as an advocate of direct interaction with end users. In other sectors, end-user ownership equates to market leadership and it is questionable if this will be the case in healthcare, where regulatory and compliance issues, such as safety, efficacy and pharmacovigilence, could be significant entry barriers. Nevertheless, major players that are focused on user needs – including Google and Apple – are working alongside health service platforms to provide value-added services, with the aim of influencing market conditions.

Risk sharing with payers leads to the use of different models that are more finance and data driven. Real-life data has been introduced – in relation to evidence development and situations that concern conditional approval conditions – as a result of remaining clinical uncertainty, where pharamaceutical companies have comitted to delivering post-market data in order to prove secondary measures or outcomes. Doctors will continue to be the main prescribers of drugs, but patients will be able to take an active role in their care journeys by using a combination of drugs, smart devices and services associated with the treatment. Those who take responsibility for the connected health interaction and data flow will control the end-user interaction to some extent, transforming pharmaceutical companies into simple drug suppliers in a service-driven environment – unless the companies decide to take on this service responsibility.

Technologies and solutions are ready

The pharmaceutical industry has a long history with risk management, and works in a tightly controlled and regulated environment. It is not surprising that it has a culture of focusing on challenges rather than opportunities that arise out of new connected health technology. Most concerns centre on security and data privacy, which are extremely important and manageable. Since the launch of smartphones, a greater number of people want to stay connected; other industries have used this to improve consumer insights and knowledge. As long as it manages the risks appropriately, the pharmaceutical sector has a prime opportunity to fulfill its patient centricity claims, as well as a desire among patients to lead their own care journey and disease management by using the connected health opportunities that smartphones and related technologies provide.

Delivering a system requires key strategic considerations and basic rules to be successful. Understanding specific stakeholder needs and challenges related to disease management creates the foundation for identifying potential value drivers. Everything must be assessed in a disease and care journey-specific context, as no disease, care journey or patients are equal.

Designing and developing a smart device and connected health solution, therefore, requires a high degree of flexibility and individual adoption options to ensure engagement, which is vital for delivering value through the patient engagement equation.

The BETACONNECT electronic auto-injector, and its associated myBEATAapp regulated connected health platform, is the first fully connected solution available in the market, which supports Bayer’s MS patients and their HCPs along every step of the care journey. This device, and the service combination product set-up, underwent regulatory assessment and has been globally approved; first in EU and most recently in the US.

Timelines and cost considerations that are associated with connected health

Smart devices are designed to meet specific needs, compared with off-the-shelf and one-size-fits-all devices; however, this does not mean that timelines to market need to be extended beyond those of an off-the-shelf device. Having a set-up of core technologies that have been tested and proved in other devices, and are what some call ‘off-the-shelf’ technologies, provides options that help to form a specific and bespoke solution. Similarly, these can be developed for the market around the same time as off-the-shelf solutions, and provide the opportunity to design and assemble bespoke device solutions that deliver features specifically for stakeholder needs, including connected health options. The roll-out of connected health solutions is also possible prior to the lauch of a device, particularly when early interaction from stakeholders adds value. This is made possible by the underlying hardware, security, integration interfaces and analytics becoming part of a standardised platform. The drug and disease specific parts of a connected health solution are primarily software and app-interface development, and there is a short lead time of 12-18 months to compare the development times of smart devices with connected health services.

There are additional costs associated with smart devices and connected health service solutions; however, significant value can be added when establishing a stronger market position and long-term relationships with stakeholders that are vested in the therapy. The move into using smart devices and connected health services has to be seen as a market transformation, and business cases have to be verified. On top of focusing on the drug, it becomes important to address its value from different parameters, including the move away from ‘pure’ treatments to preventive care models, a learning loop with end users and expanding market opportunity by using connected health as a differentiator. The pharmaceutical market need to envision its future in diseases, making one where it embraces its position as a provider of drugs and a solution to total disease management.

Influencing the pharmaceutical industry

The user focus that is occurring in other sectors is starting to impact the pharmaceuticals industry, where the need for greater patient centricity and alternative payment schemes are key trends. There is little doubt that smart devices and connected health services will play a significant role by influencing the pharmaceutical market.

Technologies and solutions are already available that create a higher degree of interaction with stakeholders along the care journey, and more solutions are being launched. Realising the value that these services can provide, and acting to implement these solutions, is an important fact that the pharmaceuticals sector needs to face by starting to understand that there are bespoke solutions that do not require the ‘reinvention of the wheel’. Instead, they need a smarter way to bring existing and proven technologies together, in order to deliver low-risk solutions that add value and successfully compete with off-the-shelf solutions regarding how long it takes to reach the market.

Contact Medicom
Contact Medicom
Connected health services and smart device solutions

Medicom, a Phillips-Medisize company, discusses the rise of smart device solutions and connected health services with World Pharmaceutical Frontiers, and focuses on how these tools enable direct interaction with end users by using real-life data. This interaction, combined with data and learning loops from these services, can differentiate drugs to meet demand in specific micro-segments.

Download White Paper
Power of value

Søren Vestergård Jacobsen and Jan Andersson from Bang & Olufsen Medicom discuss the sea change in the inhalation devices market, and how manufacturers and pharmaceuticals companies can work together to add genuine value through their inhalers.

Download White Paper
Contact Medicom
Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1%, and grew substantially across the industry which shrank by 5.1% in the global air cargo market.

Gnosis by Lesaffre unveils new website dedicated to ibSium, breakthrough beneficial live yeast supporting complete intestinal comfort

Gnosis by Lesaffre (formerly Lesaffre Human Care), business unit of Lesaffre Group dedicated to nutrition, health and personal care businesses, is raising awareness about ibSium with the launch of a website dedicated to their patented ingredient. The company opted for this online platform as a way to expand their reach and increase ibSium's visibility worldwide.

Other Ingredients

SHL makes debut at APLAR-ARA 2019

SHL Group will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress from 8-11 April in Brisbane, Australia. The congress will be held in conjunction with the Australian Rheumatology Association.

Drug Delivery Systems

Cannabis for therapeutic use

Cannabis has many potential applications: stimulating the appetite for treating weight loss in anorexia and AIDS, benefits observed in cancer-related treatment, like reductions in nausea and weakness, and synergistic action in the treatment of diseases of the central nervous system, like Dravet syndrome.

Other Ingredients

Neuro-Sys: your partner for nutraceutical development

With an increasing demand from the nutraceutical market to evaluate the efficacy of extracts, ingredients and natural products on ageing diseases, Neuro-Sys has developed an innovative platform and a standardized, tailored method for nutraceuticals, which offers customers a cost-effective way to get the pharmacological and analytical profiles of their products

R&D (formulation)

Hay fever patients can benefit from probiotics

New research from Griffith University and Winclove Probiotics, published today in the Journal of Alternative and Complementary Medicine, shows a multispecies-probiotic formulation to improve the quality of life of hay fever patients.

Probiotics

Crucial cause of eczema during childhood discovered

Butyrate, a short-chain fatty acid (SCFA) produced by bacteria in the intestine, plays a crucial role in the development of infant eczema. That’s one of the outcomes of Dutch research from Leiden University, St. Antonius Hospital Nieuwegein and Winclove Probiotics.

Probiotics

New Nektium facilities inaugurated

Several government authorities were present at the inauguration of Nektium´s new production facility, which is designed to produce high-quality, standardised botanical extracts this past Friday

Botanicals

VitaMK7 fits to clean label ingredient profile

VitaMK7, the vitamin K2 as Menaquinone-7 (MK7), produced naturally from the patented biofermentation process of the Bacillus subtilis natto, offers a CLEAN LABEL and an incomparable PURITY PROFILE, with a very high content of the all-trans active isomer (higher than 99%) and NO traces of unknown impurities.

Other Ingredients

Turkish Cargo and CSafe Global, Announce CSafe RAP Flight Approval

Turkish Cargo, one of the fastest growing brands in the air cargo sector, has approved CSafe RAP, which was recently launched for use in aircraft with CSafe Global, a leading supplier of active and passive temperature controlled solutions for pharmaceutical products.

Has palm oil reached its peak?

Foodservice operators should start to reconsider the use of palm oil in their supply chains, after a survey found 85% of consumers were against the use of palm oil in food products because of the effects its production has on the environment.

Other Ingredients

Turkish Cargo new freighter destination: Brussels, the capital of Belgium

Turkish Cargo, the fastest growing air cargo brand amongst top global air cargo carriers, is strengthening the flight network each day. Turkish Cargo has recently added Brussels, the capital city of Belgium as a destination for direct scheduled cargo flights. Turkish Cargo operates currently to 85 destinations with its 18 cargo aircrafts.

Gnosis’ customer support never stops and runs close to its partners and clients

Following the lively interest aroused by the newly released White Paper on Adonat®, Lorena Carboni, Product Support Specialist in Gnosis, held a thorough educational session with key international players to deepen the new aspects that are emerging about the use of Adonat® (SAMe -S-adenosylmethionine). New fields of application include the prevention of aging, the support to cell and organ longevity, including brain as well as sexual functions and cellular metabolism.

Other Ingredients

Turkish Cargo continues to grow in the European market

Turkish Cargo ranks 7th among the air cargo carriers of the world, rising 5 places. Turkish Cargo has achieved significant growth in the European market compared to February 2018 data from global air cargo transport data service provider World Air Cargo Data.

The upward acceleration of Turkish Cargo is maintained in 2018

Reaching 302 destinations in 121 countries with the cargo transport capacity of Turkish Airlines, which flies to the most countries worldwide, and operating additional direct cargo flights to 85 destinations thanks to the fleet of freighters, Turkish Cargo achieved a total of 55.614t of cargo sales in February, with an increase by 37.8% on year-on-year basis, as reported by the WACD (World Air Cargo Data).

Phillips-Medisize presents innovative packaging concepts and connected drug delivery devices during PharmaPack Paris

Phillips-Medisize, a Molex company will showcase its continuum of contract services including device strategy, product development and manufacture across pharmaceutical primary packaging and specialty drug delivery devices, dosing and dispensing systems, inhalators, spray applicators, as well as wearable drug delivery devices designed to improve patient engagement and drive better outcomes.

Contract Manufacturing

Constantia Flexibles gives chocolate Santa Clause his typical look

Every year, Constantia Flexibles manufactures packaging for more than 50% of the 150 million chocolate Santa Clauses produced in Germany. With the company’s patented Tepro2® method, they can be unwrapped in one piece without breaking the chocolate. The aluminum foil prevents the migration of printing ink components and other substances from the outside and offers complete protection from the light.

Packaging Materials, Containers and Containment Services

Quatrefolic®: the new food nutritional fortification substance authorised in China

With an official notification [2017, No. 8] issued on October 20th 2017 by the National Health and Family Planning Commission of the PRC (former Ministry of Health of the People’s Republic of China), Quatrefolic® has been publicly authorized as Food Nutritional Fortification Substance with a specific monograph that describes its quality (physical, chemical and microbiological) requirements.

Other Ingredients

Turkish Cargo keeps receiving QEP Accreditation

With carrying cargo capacity, new destinations and ever growing fleet, as one of the fastest-developing air cargo carrier, Turkish Cargo continues to improve its service quality to customers in 120 countries of the world

First US FDA submission of wearable drug-device combination product based on Sensile Medical’s SensePatch drug delivery technology

Sensile Medical, a global leader in large volume Injector devices based on the cost-efficient and highly accurate SenseCore micro pump technology platform, today announced that scPharmaceuticals has submitted Furosemide for s.c. administration together with Sensile's patch pump delivery system for approval with the US Food and Drug Administration (FDA). This represents the first regulatory submission in the US for Sensile Medical’s SensePatch technology as a combination product with scPharmaceuticals’ Furosemide for use in the US.

Drug Delivery Systems

The packaging world: From ketchup bottles to single-portion packaging

Traditions, culture, habits, economics, climate – these are some of the factors that influence, what we eat and which medicines we take. But they also impact how products are packaged. As a globally operating manufacturer of flexible packaging solutions, Constantia Flexibles is familiar with the range of consumer preferences and supplies the right packaging to each and every one of them.

Packaging Materials, Containers and Containment Services

Turkish Cargo to fly Kano with freighters

Turkish Cargo, providing service to 120 countries in the world, continues to expand its cargo flights network to satisfy the expectations of its customers. Cargo flights, to be operated to Kano by Turkish Cargo, will be launched on 4 July 2017.

Turkish Cargo launches cargo flights to Johannesburg and Madagascar

Turkish Cargo, providing services to 120 countries in the world thanks to its extensive transportation network, launches its scheduled cargo flights to Johannesburg, the biggest industrial and commercial center in South Africa, and Madagascar, the largest island of Vanilla Islands, on 1 July 2017.

GenMark achieves CE Mark for its ePlex(R) Blood Culture Identification Gram-Positive and Gram-Negative Panels

GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In-Vitro Diagnostic Devices Directive (98/79/EC) for its ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel and its Blood Culture Identification Gram-Negative (BCID-GN) Panel. BCID-GP and BCID-GN complete the ePlex family of sepsis panels, which also includes the BCID Fungal Pathogen (BCID-FP) Panel that achieved CE Mark in April 2017.

Imaging, Diagnostics and Analysis

Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities

Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, today announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the needs of Rentschler Biotechnologie's clients.

Contract Manufacturing

Turkish Cargo meets the most important agents of India

Turkish Cargo has met with the most important agents of India in GOA. Nearly 55 business partners from Mumbai, Delhi, Hyderabad and Chennai stations, where Turkish Cargo is online, have participated in the biggest event we have realized in India.

Turkish Cargo moves to new location in Hong Kong

Our Asian - Far East Regional Office was opened in Hong Kong, the most important air cargo centre of Asia-Far East, in 2011, and had served our customers from our office located in Wan Chai - Fenwick Street - Jubilee Centre for six years. Our Regional Directorate has moved to its new office on 88 Hing Fat Street in Causeway Bay as of March 2017 and will continue its activities at its new address.

Mythocondro® obtains GRAS status by FDA

Gnosis S.p.A. announced that the US Food and Drug Administration (FDA) has positively finalised its determination that Mythocondro®, the Non-Animal Chondroitin Sulfate, has a granted GRAS Status (Generally Recognised as Safe) for the proposed uses as a food ingredient.

Other Ingredients

Palsgaard first company to achieve CO2-neutrality in Mexico

Global emulsifier/stabiliser specialist Palsgaard announces that the company has become the first industrial company to achieve CO2-neutrality at its Mexican plant, thereby ticking off yet another production site on its to-do-list for achieving its planned global zero-carbon footprint by the end of 2020.

Emulsifiers

Plant-based food innovation with Univar and TerraVia

Univar, a distributor of food ingredients and provider of value-added services across Europe Middle East and Africa (EMEA), announced today a distribution agreement across Europe for the AlgaVia® brand of Whole Algae Ingredients from TerraVia, a plant-based food, nutrition and specialty ingredients company, including algae-based products.

Other Ingredients

Quatrefolic® and the elderly: challenges and opportunities

Gnosis steadily invests in science to discover and raise awareness of what is going on in the world of folates, emphasising scientifically proven aspects of the role of Quatrefolic® (5-methyltetrahydrofolate glucosamine salt) in health and bringing to light the new emerging breakthrough for new applications in wellbeing and health.

Other Ingredients

Anton Paar purchases future-oriented Raman technology from Silicon Valley

The measuring instrument producer Anton Paar has purchased a Raman spectroscopy product line of benchtop instruments from US company BaySpec Inc. and also licensed a technology for handheld Raman products from SciAps Inc. The product line will be implemented and further developed by Anton Paar OptoTec GmbH, a German subsidiary of Anton Paar.

Lab Equipment

CARDIOVIT AT-1 G2

SCHILLER is very pleased to introduce the 2nd generation of its most successful ECG device:Building on the solidly proven AT-1 and enhanced with the latest technology, the AT-1 G2 distinguishes itself by its outstanding signal quality and the newest interpretation algorithm.

Imaging, Diagnostics and Analysis

Focused solutions to ensure patient safety!

Whether it is injectables, dialysis or oral dosage in liquid or solid forms, Roquette has a solution. For AAPS, Roquette experts will be featuring their latest scientific solutions in plant-based pharmaceutical ingredients.

Excipients

Phillips-Medisize to be acquired by Molex LLC

Phillips-Medisize Corporation (Phillips-Medisize), a global leader in outsource design, development and manufacturing services for the medical industry announced today that it has entered into a binding agreement to be acquired by Molex LLC (Molex), a global manufacturer of complete interconnect solutions. Phillips-Medisize is a portfolio company of San Francisco, CA-based Golden Gate Capital, a private equity investment firm with approximately $15 billion of capital under management.

Contract Manufacturing

Roquette goes EXCiPACT to serve its pharmaceuticals customers

EU and US pharmaceutical regulations require drug manufacturers to audit all their starting material suppliers to demonstrate Good Manufacturing Practices (GMP) compliance. Using GMP standards designed for excipients, the high-quality third party EXCiPACT certification scheme is helping excipient users to reduce their audit burden, thus saving costs while ensuring quality.

Excipients

MSC labelled products reach 20,000

Today the Marine Stewardship Council (MSC) reached an important milestone with the launch of the 20,000th MSC labelled product, Las Cuarenta Paella. The ready-made frozen meal is now available in Netto stores across Germany. The paella contains pollock from Alaska and Russia, blue shell mussels from Denmark, and shrimps from Suriname.

Supply Chain Management

Haselmeier self-injection devices go connected

Haselmeier has added connectivity to its devices portfolio with the announcement of its new Axis-D-Connect Disposable Pen Injector. Haselmeier has partnered with the Austrian Institute of Technology GmbH (AIT) to equip its Axis-D platform pen with AIT`s cartridge fill-level measurement system.

Drug Delivery Systems

Clean label for a healthier world

At Azelis we place customer and principles at the heart of our activities and our aim is to grow by creating value together with our partners. We wish to continue to build upon the complete package of innovative ingredients, technical solutions and service to meet our customers' and consumers' desire for healthy, tasty and convenient foods.

Flavours, Flavour Enhancers and Fragrances

Dutch Postcode Lottery extends partnership with the Marine Stewardship Council

The Dutch Postcode Lottery has extended its funding support to the Marine Stewardship Council (MSC) with a €2.5 million grant over the next five years, effective from January 2016. The Dutch Postcode Lottery is the Netherlands' largest charity lottery, supporting more than 90 organisations working in the fields of nature and the environment, development cooperation, human rights and social cohesion.

Supply Chain Management

Sensile Medical wins Swiss Technology Award

The medical device company Sensile Medical, based in the Swiss Canton of Solothurn, has won the Swiss Technology Award in the category of "Innovation Leader". The company develops and produces high-tech micropumps used to dose and deliver liquid medicines.

Drug Delivery Systems

Antares Vision Experience: at the new facility

With three times the space, light and transparent indoors walls, Antares Vision designed the building in Travagliato (Brescia) based on quality and transparency, values that it shares with the pharmaceutical industry. It also created a permanent centre of excellence for training.

Call for entries: Eppendorf Award 2016

From 1 October 2015 until 15 January 2016 young researchers working in Europe who are not older than 35 years can apply for the Eppendorf Award for Young European Investigators. This highly prestigious €20,000 prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.

Biotechnology Equipment and Materials

In Brazil for the great challenge of pharmaceutical drug serialisation

By the end of 2016 the pharmaceutical industries working in Brazil must comply with the track and trace regulation. The objective is to increase patient safety thanks to reliable traceability and anti-counterfeiting. With a local branch, Antares Vision is close to its customers who are in the process of implementing serialisation and aggregation systems. Here we present three cases, with very diverse needs, where it has been applied.

Bürkert presents a flexible alternative to solenoid valves

With a new series of electrically controlled motor valves Bürkert expands the spectrum of components for fluid control. The new valves are designed for space-saving and energy-saving operation. They also achieve a very fine linear characteristic and low hysteresis in the control of fluid flows.

Lab Equipment

Robust T-CUT tubular modules for micro and ultra filtration

The membrane and module manufacturer CUT Membrane Technology, since early 2013 a subsidiary of the Bürkert Group, has presented a new product family of T-CUT tubular modules at the ACHEMA trade fair. The robust tubular modules made of PVDF and PES are available with different membrane materials and cut-offs for individual membrane solutions.

Lab Equipment

Bürkert presents a flexible alternative to solenoid valves

With a new series of electrically controlled motor valves Bürkert expands the spectrum of components for fluid control. The new valves are designed for space-saving and energy-saving operation. They also achieve a very fine linear characteristic and low hysteresis in the control of fluid flows.

Lab Equipment

Haselmeier honoured at the international Red Dot Design Award 2015

Haselmeier is proud to announce yet another award for one of its products. Presented annually, the 'Red Dot Award' is divided into three design sections. In terms of cross-border and cross-sector reach, it is considered the most distinguished accolade for high-quality design. At the "Red Dot Award: Product Design 2015", Haselmeier achieved a thoroughly convincing result.

Drug Delivery Systems

Haselmeier 2.0: Redesign of the website

Today, the world's largest and fastest provider of information is the internet. As markets become ever more transparent, the importance of websites continues to grow - a fact Haselmeier AG recognised long ago. Its maxim of "innovation brings progress and changes thinking" will set new standards in networking and digitisation.

Drug Delivery Systems

Bürkert lays symbolic foundation stone for new buildings

With a cornerstone ceremony on 22 May 2015 the planned new buildings at the Ingelfingen-Criesbach location of the fluid technology specialist Bürkert have entered the next phase. By the end of July 2016, and with an investment sum of around €30 million, the 'Bürkert Campus Criesbach' will include a production building with offices, a training centre, a parking garage, a company restaurant and an 18m high-bay warehouse.

Lab Equipment

New Medium Fat Soft Cheese Offers Potential Cost Saving

Dairy ingredients specialist, Meadow Cheese has launched a new Medium Fat Soft Cheese as a cost-saving alternative to Cheddar cheese. This innovative cheese looks and performs like Cheddar in food production, making it ideal for a range of applications such as ready meals, sandwiches, pizza, fillings and toppings. With current fluctuating dairy prices, the use of medium fat soft cheese means that manufacturers are able to better manage the pricing on their finished products. The labelling of the cheese is similar to Mozzarella and other fresh un-ripened cheese.

Supply Chain Management

A Nutritional and Convenient Start to the Day with BENEO

BENEO, one of the leading manufacturers of functional nutrients, is featuring its new product concepts for breakfast beverages on stand B1 #325 at this year’s drinktec. Visitors have the opportunity to taste the company’s product ideas at the ‘New Beverage Concepts’ innovation platform and find out more about the nutritional and technical benefits of BENEO’s naturally derived ingredients.

Carbohydrates, Starches and Wheat Glutens

Latest Research from Flavex on Pomegranate Seed Oil offers new Prospects for Food Supplements

The pioneer in supercritical fluid extraction (SFE), the german company Flavex, presents the latest research on the physiological properties of pomegranate seed oil and points out its application in food and food supplements. Pomegranate is a superfruit: more than 200 peer reviewed scientific papers have been published about positive health effects of this amazing fruit! In vitro, in vivo and clinical studies revealed positive effects of the antioxidative, antiinflammatory, antisclerotic and anticancerogenic properties of pomegranate ingredients. However, only until very recently, the importance of the seed oil has been largely overlooked. Recent studies have also begun to suggest possible synergistic interactions between aqueous and lipid phases of the whole fruit including its seeds.

Botanicals

Solvay to boost worldwide vanillin production capacity with new manufacturing facility in China

Solvay to boost worldwide vanillin production capacity with new manufacturing facility in China Lyon, France July 1, 2013 --- Solvay announces today its decision to build a new state-of-the-art facility to manufacture vanillin in Zhenjiang City, in China’s Jiangsu Province, boosting its production capacities by 40% and enabling the Group to better serve the fast-growing Asian market.

Flavours, Flavour Enhancers and Fragrances

What does the new Food Information to Consumer Regulation (FIC) hold in store for us?

What does the new Food Information to Consumer Regulation (FIC) hold in store for us? More consumer protection, more consumer information, but many unsolved issues as well Things will get serious on 13 December 2014: Regulation (EU) No 1169/2011 on the provision of food information to consumers (FIC), which came into force in December 2011, will become applicable. From that date the general food labelling rules will be regulated on a European level - this also includes distance selling.

Other Ingredients

FrieslandCampina DMV awarded with certification FSSC 22000

FrieslandCampina DMV’s food safety management systems are now subject to a non-profit safety standard. This will replace all the various standards customers in different countries asked for in the past. “In future one certificate on the wall will be enough. One standard fits all, so to speak,” explains drs. ing. Leo van Outersterp, Manager Quality at DMV. The company is very pleased to have recently been awarded the Certificate of Approval by Lloyd’s Register Quality Assessment.

Other Ingredients

DMV specialists ready to grow your business in Performance & Lifestyle Nutrition

FrieslandCampina DMV has been building a Market Unit Team to advise customers on how they can make an impact on the Performance and Lifestyle Nutrition market comprising of sports nutrition, weight management and healthy aging. Twelve top professionals on the team are ready to help you get the best products with dairy ingredients. They include innovative scientists and specialised nutritionists.

Other Ingredients

Beer Awards 2013 Winners Announced

The most prestigious award ceremony in the beer industry was held on May 14th in Prague, acknowledging the very best beer and beer brand styles. The evening was a great success that offered excellent networking opportunities for all major and minor breweries in attendance.

Supply Chain Management

Contact Medicom
Contact Medicom
Contact Medicom
Contact Medicom
Contact Medicom
Medicom

Medicom